Treatment of refractory psoriasis with dermatomyositis using upadacitinib

Clin Exp Rheumatol. 2024 Feb;42(2):458-459. doi: 10.55563/clinexprheumatol/ki4jbt. Epub 2023 Dec 27.

Authors

Zining Xu¹, Bingyang Xu¹, Bin Zhao², Hailong Gao³, Shuhong Ye¹, Jiawen Wu⁴

Affiliations

¹ Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
² Department of Dermatology, Xi'an International Medical Center Hospital, Xi'an, China.
³ Civil Aviation, Xi'an Hospital, Xi'an, China.
⁴ Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. jiawen702@126.com.

PMID: 38153132
DOI: 10.55563/clinexprheumatol/ki4jbt

No abstract available

Publication types

Letter

MeSH terms

Dermatomyositis* / complications
Dermatomyositis* / diagnosis
Dermatomyositis* / drug therapy
Heterocyclic Compounds, 3-Ring
Humans
Psoriasis* / complications
Psoriasis* / diagnosis
Psoriasis* / drug therapy

Substances

upadacitinib
Heterocyclic Compounds, 3-Ring